Monday 18 September 2017

Global Obesity and Overweight Treatment Market 2017 to 2022 - Industry, Applications, Market Size, Segmentation, Company, Share: Acute Market Reports

This report studies the Obesity and Overweight Treatment market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Obesity and Overweight Treatment market by product and Application/end industries.


The global Obesity and Overweight Treatment market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
United States will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Obesity and Overweight Treatment.
EU also play important roles in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX.


The major players in global market include
VIVUS, Inc.
Arena Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Novo Nordisk A/S
Allergan Plc
Medtronic
Ethicon
Cousin Biotech,
EnteroMedics, Inc.
USGI Medical, Inc.
Geographically, this report split global into several key Regions, with, revenue (million USD), market share and growth rate of Obesity and Overweight Treatment for these regions, from 2012 to 2022 (forecast)
United States
EU
Japan
China
India
Southeast Asia
On the basis of product, the Obesity and Overweight Treatment market is primarily split into
Gastric Electrical Stimulation
Ingestible Capsules
Smart Pill
Electronic Drug Delivery Systems


Table of Content :
1 Industry Overview
1.1 Obesity and Overweight Treatment Market Overview
1.1.1 Obesity and Overweight Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Obesity and Overweight Treatment Market Size and Analysis by Regions (2012-2017)
1.2.1 United States Obesity and Overweight Treatment Market Status and Outlook
1.2.2 EU Obesity and Overweight Treatment Market Status and Outlook
1.2.3 Japan Obesity and Overweight Treatment Market Status and Outlook
1.2.4 China Obesity and Overweight Treatment Market Status and Outlook
1.2.5 India Obesity and Overweight Treatment Market Status and Outlook
1.2.6 Southeast Asia Obesity and Overweight Treatment Market Status and Outlook
1.3 Classification of Obesity and Overweight Treatment by Product
1.3.1 Global Obesity and Overweight Treatment Revenue (Million USD) and Growth (%) Comparison by Product (2012-2022)
1.3.2 Global Obesity and Overweight Treatment Revenue (Million USD) Market Share (%) by Product in 2016
1.3.3 Gastric Electrical Stimulation
1.3.4 Ingestible Capsules
1.3.5 Smart Pill
1.3.4 Electronic Drug Delivery Systems
1.4 Obesity and Overweight Treatment Market by End Users/Application
1.5 Population of Obesity and Overweight by Region
2 Global Obesity and Overweight Treatment Competition Analysis by Players
2.1 Global Obesity and Overweight Treatment Market Size (Million USD) by Players (2012-2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles and Key Data
3.1 VIVUS, Inc.
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 VIVUS, Inc. Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.1.5 Recent Developments
3.2 Arena Pharmaceuticals, Inc.
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Arena Pharmaceuticals, Inc. Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.2.5 Recent Developments
3.3 F. Hoffmann-La Roche Ltd.
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 F. Hoffmann-La Roche Ltd. Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.3.5 Recent Developments
3.4 Novo Nordisk A/S
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Novo Nordisk A/S Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.4.5 Recent Developments
3.5 Allergan Plc
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Allergan Plc Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.5.5 Recent Developments
3.6 Medtronic
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Medtronic Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.6.5 Recent Developments
3.7 Ethicon
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Ethicon Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.7.5 Recent Developments
3.8 Cousin Biotech,
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cousin Biotech, Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.8.5 Recent Developments
3.9 EnteroMedics, Inc.
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 EnteroMedics, Inc. Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.9.5 Recent Developments
3.10 USGI Medical, Inc.
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 USGI Medical, Inc. Obesity and Overweight Treatment Revenue (Million USD) (2012-2017)
3.10.5 Recent Developments
4 Global Obesity and Overweight Treatment Market Size by Product and Application (2012-2017)
4.1 Global Obesity and Overweight Treatment Market Size by Product (2012-2017)
4.2 Global Obesity and Overweight Treatment Market Size by Application (2012-2017)
4.3 Potential Application of Obesity and Overweight Treatment in Future
4.4 Top Consumer / End Users of Obesity and Overweight Treatment

About – Acute Market Reports:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us:
Name : Chris Paul
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)